Regeneron Pharmaceuticals, Inc. (REGN)

Market Closed

10 Aug, 20:00

NASDAQ (NGS)

808. 05

+23.69

+3.0203%

83.25B Market Cap

24.52 P/E Ratio

0.22% Div Yield

981,832 Volume

42.79 Eps

$ 784.36

Previous Close

Investors:

Analysts:

Day Range

775.83 809.02

Year Range

541 821.11

Want to track REGN and more in your Portfolio? 🎯

Regeneron Pharmaceuticals, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
TPF Tribridge Partners Financial LLC Tribridge Partners Financial LLC	343	$192,858.61	$261,582.09	$68,723.48	35.63%
ESL Element Squared LLC Element Squared LLC	3,083	$2.36M	$2.35M	-$9,228.23	-0.39%
BWL Basepoint Wealth LLC Basepoint Wealth LLC	51	$39,542	$39,996.24	$454.24	1.15%
United Financial Planning Group LLC United Financial Planning Group LLC	7	$5,408.5	$5,380.06	-$28.44	-0.53%
Jon Borer Capitolis Liquid Global Markets LLC	75,000	$40.61M	$57.2M	$16.59M	40.85%
TAF Tred Avon Family Wealth LLC Tred Avon Family Wealth LLC	531	$303,655.85	$416,431.43	$112,775.58	37.14%
Wallace Jones WJ Financial Advisors LLC	865	$487,205.04	$659,674.95	$172,469.91	35.4%
Kerr Financial Planning Corp Kerr Financial Planning Corp	10	$6,048.7	$7,626.3	$1,577.6	26.08%
KCS Kepler Cheuvreux (Suisse) SA Kepler Cheuvreux (Suisse) SA	921	$574,279	$702,382.23	$128,103.23	22.31%
Michael Alfred Alpine Fox Capital LLC	1,000	$562,270	$762,630	$200,360	35.63%
Stuart E. Greenfield Greenfield Seitz Capital Management LLC	3,014	$2.44M	$2.3M	-$141,643.83	-5.8%